LivaNova (LIVN) EPS (Weighted Average and Diluted) (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.57% |
| Dec 31, 2025 | 14.29% |
| Sep 30, 2025 | -2.00% |
| Jun 30, 2025 | 108.32% |
| Mar 31, 2025 | -683.50% |
| Dec 31, 2024 | 71.67% |
| Sep 30, 2024 | 100.00% |
| Jun 30, 2024 | 138.46% |
| Mar 31, 2024 | -360.00% |
| Dec 31, 2023 | 314.29% |
| Sep 30, 2023 | -800.00% |
| Jun 30, 2023 | -85.71% |
| Mar 31, 2023 | 366.67% |
| Dec 31, 2022 | 101.49% |
| Sep 30, 2022 | -770.00% |
| Jun 30, 2022 | 400.00% |
| Mar 31, 2022 | 160.00% |
| Dec 31, 2021 | 88.10% |
| Sep 30, 2021 | 26.96% |
| Jun 30, 2021 | -82.54% |
| Mar 31, 2021 | 89.10% |
| Dec 31, 2020 | -1,826.67% |
| Sep 30, 2020 | 83.70% |
| Jun 30, 2020 | -338.96% |
| Mar 31, 2020 | 126.01% |
| Dec 31, 2019 | -548.48% |
| Sep 30, 2019 | 210.00% |
| Jun 30, 2019 | -93.55% |
| Mar 31, 2019 | 92.86% |
| Dec 31, 2018 | -2,793.33% |
| Sep 30, 2018 | -148.39% |
| Jun 30, 2018 | -13.89% |
| Mar 31, 2018 | 115.52% |
| Dec 31, 2017 | -507.02% |
| Sep 30, 2017 | -40.00% |
| Jun 30, 2017 | 251.85% |
| Mar 31, 2017 | 144.26% |
| Dec 31, 2016 | -569.23% |
| Sep 30, 2016 | -50.00% |
| Jun 30, 2016 | 131.33% |
| Mar 31, 2016 | -82.47% |
| Oct 18, 2015 | -304.26% |
| Jul 24, 2015 | 17.50% |